![Barry T. Mori](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barry T. Mori
Director of Finance/CFO at InterX, Inc.
Barry T. Mori active positions
Companies | Position | Start | End |
---|---|---|---|
InterX, Inc.
![]() InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Director/Board Member | - | - |
Director of Finance/CFO | - | - |
Career history of Barry T. Mori
Former positions of Barry T. Mori
Companies | Position | Start | End |
---|---|---|---|
Perquest, Inc.
![]() Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Director of Finance/CFO | 01/10/2005 | - |
Training of Barry T. Mori
University of California, Los Angeles | Masters Business Admin |
University of California, Berkeley | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Director of Finance/CFO | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Perquest, Inc.
![]() Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Commercial Services |
InterX, Inc.
![]() InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
- Stock Market
- Insiders
- Barry T. Mori
- Experience